Fusion in the ETS gene family and prostate cancer

Por Narod, S A, Seth, A, Nam, R
Publicado em 2008

Prostate cancer: 2. Natural history

Por Nam, R K, Jewett, M A, Krahn, M D
Publicado em 1998

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer

Por Akbari, M R, Wallis, C J D, Toi, A, Trachtenberg, J, Sun, P, Narod, S A, Nam, R K
Publicado no Br J Cancer (2014)

Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts

Por Barwick, B G, Abramovitz, M, Kodani, M, Moreno, C S, Nam, R, Tang, W, Bouzyk, M, Seth, A, Leyland-Jones, B
Publicado em 2010

Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer

Por Wallis, C J D, Cheung, P, Herschorn, S, Saskin, R, Su, J, Klotz, L H, Kulkarni, G S, Lee, Y, Kodama, R T, Narod, S A, Nam, R K
Publicado no Br J Cancer (2015)

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

Por Nam, R K, Sugar, L, Yang, W, Srivastava, S, Klotz, L H, Yang, L-Y, Stanimirovic, A, Encioiu, E, Neill, M, Loblaw, D A, Trachtenberg, J, Narod, S A, Seth, A
Publicado em 2007

Rapid progression of prostate cancer in men with a BRCA2 mutation

Por Narod, S A, Neuhausen, S, Vichodez, G, Armel, S, Lynch, H T, Ghadirian, P, Cummings, S, Olopade, O, Stoppa-Lyonnet, D, Couch, F, Wagner, T, Warner, E, Foulkes, W D, Saal, H, Weitzel, J, Tulman, A, Poll, A, Nam, R, Sun, P
Publicado em 2008